16.11.2017 14:00:00
|
Omnicell To Present At The 29th Annual Piper Jaffray Healthcare Conference
MOUNTAIN VIEW, Calif., Nov. 16, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at the 29th Annual Piper Jaffray Healthcare Conference at the Lotte New York Palace, New York, NY.
Omnicell Speakers: Randall A. Lipps, founder, chairman, president & CEO and Peter Kuipers, executive vice president & CFO
Date:Tuesday, November 28, 2017
Time: 8:30 a.m. ET
Location: Lotte New York Palace, New York, NY
Availability: The audio-webcast of the live presentation may be accessed by visiting:
http://ir.omnicell.com/events.cfm
Following the conference, a replay of the audio-webcast will be archived for 30 days on the Omnicell website.
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.
Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.
Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.
Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.
OMCL-E
View original content with multimedia:http://www.prnewswire.com/news-releases/omnicell-to-present-at-the-29th-annual-piper-jaffray-healthcare-conference-300556183.html
SOURCE Omnicell, Inc.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Omnicell Inc.mehr Nachrichten
22.01.25 |
Erste Schätzungen: Omnicell veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net) | |
21.01.25 |
NASDAQ Composite Index-Papier Omnicell-Aktie: So viel Gewinn hätte ein Omnicell-Investment von vor einem Jahr abgeworfen (finanzen.at) | |
14.01.25 |
NASDAQ Composite Index-Wert Omnicell-Aktie: So viel Gewinn hätte ein Omnicell-Investment von vor 10 Jahren abgeworfen (finanzen.at) | |
07.01.25 |
NASDAQ Composite Index-Papier Omnicell-Aktie: So viel hätten Anleger an einem Omnicell-Investment von vor 5 Jahren verloren (finanzen.at) | |
31.12.24 |
NASDAQ Composite Index-Papier Omnicell-Aktie: So viel Verlust hätte ein Investment in Omnicell von vor 3 Jahren bedeutet (finanzen.at) | |
24.12.24 |
Pluszeichen in New York: NASDAQ Composite klettert zum Handelsende (finanzen.at) | |
24.12.24 |
Zuversicht in New York: NASDAQ Composite-Anleger greifen am Nachmittag zu (finanzen.at) | |
24.12.24 |
Freundlicher Handel: NASDAQ Composite-Anleger greifen am Dienstagmittag zu (finanzen.at) |
Analysen zu Omnicell Inc.mehr Analysen
Aktien in diesem Artikel
Omnicell Inc. | 41,20 | 0,49% |